4 Einträge gefunden

1. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group

   1. Escherich, Gabriele
   2. Zur Stadt, Udo
   3. Borkhardt, Arndt
   4. Dilloo, Dagmar
   5. Faber, Jörg
   6. Feuchtinger, Tobias
   7. Imschweiler, Thomas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Thirteen-month-old girl with hyporegenerative macrocytic anemia due to Brown-Vialetto-Van Laere syndrome 2

   1. Naami, Nibras
   2. Borkhardt, Arndt
   3. Yoshimi, Ayami
   4. Grinstein, Lev
   5. Escherich, Gabriele

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics

   1. Eckert, Cornelia
   2. Groeneveld-Krentz, Stefanie
   3. Kirschner-Schwabe, Renate
   4. Hagedorn, Nikola
   5. Chen-Santel, Christiane
   6. Bader, Peter
   7. Borkhardt, Arndt

   2019 - Forschungsinformationssystem des UKE
4. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

   1. Eckert, Cornelia
   2. von Stackelberg, Arend
   3. Seeger, Karl
   4. Groeneveld, Tom W L
   5. Peters, Christina
   6. Klingebiel, Thomas
   7. Borkhardt, Arndt

   2013 - Forschungsinformationssystem des UKE